PetMed (PETS) Surpasses Q2 Earnings Estimates

Financial Performance - PetMed (PETS) reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of a loss of $0.06 per share, compared to break-even earnings per share a year ago, representing an earnings surprise of 283.33% [1] - The company posted revenues of $59.57 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 9.77%, and down from $71 million in the same quarter last year [2] - PetMed has surpassed consensus EPS estimates two times over the last four quarters but has not beaten consensus revenue estimates during that period [2] Stock Performance - PetMed shares have declined approximately 43.6% since the beginning of the year, while the S&P 500 has gained 21.2% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $64.51 million, and for the current fiscal year, it is $0.08 on revenues of $265.56 million [7] - The estimate revisions trend for PetMed is currently favorable, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Internet - Commerce industry, to which PetMed belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Chewy (CHWY), another company in the same industry, is expected to report quarterly earnings of $0.23 per share, reflecting a year-over-year increase of 53.3% [9]